Current COVID-19 vaccine trials in high-income countries: are placebo-controlled trials ethical?

Clin Microbiol Infect

Division of Medical Ethics, Grossman School of Medicine, NYU Langone Medical Center, New York, NY, USA.

Published: November 2021

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349440PMC
http://dx.doi.org/10.1016/j.cmi.2021.08.005DOI Listing

Publication Analysis

Top Keywords

current covid-19
4
covid-19 vaccine
4
vaccine trials
4
trials high-income
4
high-income countries
4
countries placebo-controlled
4
placebo-controlled trials
4
trials ethical?
4
trials
2
current
1

Similar Publications

In response to problems of poor sampling quality, low sensitivity, and high demand for medical personnel regarding the current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) oropharyngeal (OP) swab sampling used in China, we aimed to evaluate the diagnostic performance and acceptability of saliva-based nucleic acid amplification tests (NAATs) in China. The results showed that, using nasopharyngeal (NP) swab results as the gold standard, the overall sensitivities for saliva specimens and OP swabs were 93.3 % and 85.

View Article and Find Full Text PDF

Saving sheep - On extinction narratives in Namibian Swakara farming.

Camb Prism Extinct

March 2024

Faculty of Humanities and Social Sciences, Cultural and Social Anthropology, University of Bayreuth, Bayreuth, Germany.

The Namibian Swakara industry, a type of sheep farming focused on the production of lamb pelts for the fashion industry, currently faces a crisis situation. Formerly one of the most important export products from Namibia, a combination of drought, falling pelt prices and the effects of the COVID-19 pandemic now threaten the survival of Swakara, the Namibian Karakul. The current crisis is articulated in extinction narratives.

View Article and Find Full Text PDF

Background: Multimorbidity of chronic diseases has become an increasingly serious public health problem. However, the research on the current situation of multimorbidity in the older adults in Jiangsu, China is relatively lacking.

Methods: We surveyed a total of 229,926 inpatients aged above 60 and with two or more chronic diseases in the First Affiliated Hospital with Nanjing Medical University from January 1, 2015 to December 31, 2021.

View Article and Find Full Text PDF

Biosafety and immunology: An interdisciplinary field for health priority.

Biosaf Health

October 2024

NHC Key Laboratory of Biosafety, National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), Research Unit of Adaptive Evolution and Control of Emerging Viruses, Chinese Academy of Medical Sciences, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.

Biosafety hazards can trigger a host immune response after infection, invasion, or contact with the host. Whether infection with a microorganism results in disease or biosafety concerns depends to a large extent on the immune status of the population. Therefore, it is essential to investigate the immunological characteristics of the host and the mechanisms of biological threats and agents to protect the host more effectively.

View Article and Find Full Text PDF

An online survey among convalescents 5 months post SARS-CoV-2 infection in China.

Biosaf Health

August 2024

NHC Key Laboratory of Biosafety, National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing 102206, China.

The effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection persist months and years after recovery. We conducted an online survey to assess the health condition of convalescents approximately 5 months following the primary infection of SARS-CoV-2. The study recruited 5,510 individuals who were primary infected, 626 participants who had experienced reinfection, and 521 participants who were without infective history.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!